JAM
BEAM icon

Jupiter Asset Management’s Beam Therapeutics BEAM Stock Holding History

Jupiter Asset Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3M Buy
445,718
+421,658
+1,753% +$12.7M 0.08% 260
2026
Q1 		$573K Buy
+24,060
New +$668K ﹤0.01% 450

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Jupiter Asset Management's BEAM Position: Q2 2026 in Review

Jupiter Asset Management increased its Beam Therapeutics (BEAM) stake by 1,753% in Q2 2026, buying an estimated $12.7M and bringing the position to 445,718 shares worth $15.3M. The position accounts for 0.08% of the portfolio, ranked #260.

Jupiter Asset Management first reported a position in BEAM in Q1 2026 and has held it in 2 quarters since. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Jupiter Asset Management held 445,718 shares of Beam Therapeutics worth $15.3M as of Q2 2026.
  • Jupiter Asset Management bought 421,658 Beam Therapeutics shares in Q2 2026, an estimated $12.7M.
  • Beam Therapeutics made up 0.08% of Jupiter Asset Management's portfolio in Q2 2026, its #260 holding.
  • Jupiter Asset Management first reported a position in Beam Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.